BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14508884)

  • 1. MBI-226. Micrologix/Fujisawa.
    Isaacson RE
    Curr Opin Investig Drugs; 2003 Aug; 4(8):999-1003. PubMed ID: 14508884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
    Koldehoff M; Zakrzewski JL
    Int J Antimicrob Agents; 2004 Nov; 24(5):491-5. PubMed ID: 15519483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host defense peptides for use as potential therapeutics.
    Zhang L; Falla TJ
    Curr Opin Investig Drugs; 2009 Feb; 10(2):164-71. PubMed ID: 19197794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balofloxacin Choongwae.
    Alksne L
    Curr Opin Investig Drugs; 2003 Feb; 4(2):224-9. PubMed ID: 12669387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of catheter-related bloodstream infections: looking to the department of veterans affairs health care system for guidance.
    Snydman DR
    Mayo Clin Proc; 2007 Jun; 82(6):665. PubMed ID: 17550744
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic lock technique to reduce central venous catheter-related bacteremia.
    Toltzis P
    Pediatr Infect Dis J; 2006 May; 25(5):449-50. PubMed ID: 16645511
    [No Abstract]   [Full Text] [Related]  

  • 8. Resiquimod 3M.
    Jones T
    Curr Opin Investig Drugs; 2003 Feb; 4(2):214-8. PubMed ID: 12669385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models.
    Rubinchik E; Dugourd D; Algara T; Pasetka C; Friedland HD
    Int J Antimicrob Agents; 2009 Nov; 34(5):457-61. PubMed ID: 19524411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.
    Lipsky BA; Holroyd KJ; Zasloff M
    Clin Infect Dis; 2008 Dec; 47(12):1537-45. PubMed ID: 18990064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microorganisms responsible for femoral catheter-related bloodstream infection.
    Lorente L; Mora ML; Jiménez A
    Crit Care Med; 2008 Feb; 36(2):657-8. PubMed ID: 18216644
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigational antimicrobial drugs for bloodstream infections.
    Korbila IP; Falagas ME
    Curr Opin Investig Drugs; 2008 Aug; 9(8):871-8. PubMed ID: 18666035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremia.
    Castagnola E; Moroni C; Gandullia P; Oddone M; Peri C; Casciaro R; De Alessandri A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1120-1. PubMed ID: 16495284
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections.
    Peppard WJ; Schuenke CD
    Curr Opin Investig Drugs; 2008 Feb; 9(2):210-25. PubMed ID: 18246524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
    Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
    J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial.
    Broom J; Woods M; Allworth A; McCarthy J; Faoagali J; Macdonald S; Pithie A
    Scand J Infect Dis; 2008; 40(5):399-406. PubMed ID: 18418801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of central venous catheter: prevention of thrombosis and bacteremia].
    Lomonte C; Basile C
    G Ital Nefrol; 2009; 26(1):73-80. PubMed ID: 19255966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
    Fletcher PS; Shattock RJ
    Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
    Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.